methotrexate
Showing 1 - 25 of 944
Alopecia Areata Trial in Assiut (Methotrexate, Triamcinolone Acetonide)
Not yet recruiting
- Alopecia Areata
- Methotrexate
- Triamcinolone Acetonide
-
Assiut, EgyptAl-Azhar University
Oct 11, 2023
Arthritis, Arthralgia Trial (Methotrexate)
Not yet recruiting
- Arthritis
- Arthralgia
- Methotrexate
- (no location specified)
Aug 18, 2023
Bullous Pemphigoid Trial in Bhubaneswar (Prednisolone, Dapsone, Methotrexate)
Not yet recruiting
- Bullous Pemphigoid
- Prednisolone
- +2 more
-
Bhubaneswar, Odisha, IndiaAIIMS Bhubaneswar
Aug 9, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Ectopic Pregnancy Trial in Tehran (Letrozole, methotrexate)
Active, not recruiting
- Ectopic Pregnancy
- Letrozole
- methotrexate
-
Tehran, Iran, Islamic Republic ofImam Khomeini Hospital Complex
Jun 23, 2023
Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)
Not yet recruiting
- Non-Hodgkin Lymphoma
- Tafasitamab
- +3 more
-
Cologne, GermanyUniversity of Cologne
Oct 14, 2022
Primary CNS Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Methotrexate)
Completed
- Primary Central Nervous System Lymphoma
- Rituximab
- +2 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 18, 2022
Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)
Recruiting
- Breast Cancer
- Cyclophosphamide
- +2 more
-
Chicago, IllinoisUniversity of Illinois
Oct 18, 2023
Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib
- +2 more
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022
Arthritis, Rheumatoid Trial in Beijing (Guizhi Shaoyao Zhimu decoction Combined with methotrexate, Methotrexate)
Not yet recruiting
- Arthritis, Rheumatoid
- Guizhi Shaoyao Zhimu decoction Combined with methotrexate
- Methotrexate
-
Beijing, ChinaChina-Japan Friendship Hospital
Aug 17, 2022
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022
Healthy Participants Trial (Methotrexate, Leucovorin, BMS-986371)
Recruiting
- Healthy Participants
- Methotrexate
- +3 more
-
Miami, FloridaQuotient Sciences Miami
Oct 10, 2022
Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)
Completed
- Thyroid Associated Orbitopathy
- Methotrexate
- Triamcinolone Acetonide
-
Cairo, EgyptCairo University
Jul 15, 2022
Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)
Recruiting
- Brain Tumor Recurrent
- Methotrexate
- +2 more
-
Houston, TexasUTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022
Non-melanoma Skin Cancers Trial in Zagazig (Methotrexate)
Completed
- Non-melanoma Skin Cancers
- Methotrexate
-
Zagazig, Sharkia, EgyptZagazig university
Apr 6, 2022
Psoriasis Trial in Aswan (Narrowband ultraviolet B, Methotrexate)
Active, not recruiting
- Psoriasis
- Narrowband ultraviolet B
- Methotrexate
-
Aswan, Aswan Governorate, Egypt, EgyptAswan University - Faculty of Medicine
Jun 16, 2022
CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)
Not yet recruiting
- Central Nervous System Lymphoma
- Selinexor
- +2 more
-
Hefei, Anhui, China
- +4 more
Jan 26, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Vitiligo Trial in France (Methotrexate, Placebos)
Not yet recruiting
- Vitiligo
- Methotrexate
- Placebos
-
Bordeaux, France
- +3 more
May 12, 2022
Erythema Nodosum Leprosum Trial in Worldwide (Methotrexate, Placebo, Prednisolone)
Not yet recruiting
- Erythema Nodosum Leprosum
- Methotrexate
- +2 more
-
Dhaka, Bangladesh
- +6 more
Aug 23, 2022
Hypophosphatasia Trial (methotrexate, rituximab, bortezomib)
Not yet recruiting
- Hypophosphatasia
- methotrexate
- +4 more
- (no location specified)
Aug 23, 2023